TOBI (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the TOBI drug offered from Novartis Pharmaceuticals Corporation. This Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | Tobramycin |
| SUBSTANCE NAME: | TOBRAMYCIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1997-12-22 |
| END MARKETING DATE: | 0000-00-00 |
TOBI HUMAN PRESCRIPTION DRUG Details:
| Item Description | TOBI from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300(mg/5mL) |
| START MARKETING DATE: | 1997-12-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0494_00c22bc4-d60e-4ff1-a572-22d871717c19 |
| PRODUCT NDC: | 0078-0494 |
| APPLICATION NUMBER: | NDA050753 |
Other TOBRAMYCIN Pharmaceutical Manufacturers / Labelers:
